Prostate cancer vaccine (KAEL-GemVax)

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameProstate cancer vaccine (KAEL-GemVax)
Drug Alias Name前列腺癌疫苗 - KAEL-GemVaxONY-P2ONY-P1ONY-POnyvax-P
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesOnyvax Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKael-Gemvax Co Ltd
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A